Physician profile
Leslie E Simons
NPI 1508827270
$368.08
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $228 · 2023: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $115.18 | 2022-2023 | |
| Jazz Pharmaceuticals INC. | $65.50 | 2022-2023 | |
| Argenx US, INC. | $34.29 | 2022-2023 | Vyvgart |
| Ipsen Biopharmaceuticals, INC | $24.97 | 2022 | |
| Novo Nordisk INC | $24.24 | 2023 | |
| Acorda Therapeutics, INC | $23.07 | 2022 | |
| Avion Pharmaceuticals | $18.51 | 2022 | |
| Genentech USA, INC. | $16.70 | 2023 | Ocrevus, Enspryng |
| Cala Health, INC. | $16.50 | 2022 | |
| Biogen, INC. | $15.91 | 2023 | Spinraza |
| Neurelis, INC. | $13.21 | 2023 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Simons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.